Inbunden, Engelska, 2009
Del i serien Cancer Treatment and Research
Acute Myelogenous Leukemia
Genetics, Biology and Therapy
739 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Finns i fler format
Beskrivning
Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as the population ages. Over the past 15 years, genetic mechanisms underlying AML have begun to unfold. Additional research in this area has helped identify key components and characteristics. Consequently, targeted therapy of AML is receiving much attention. It is the hope of researchers that as with chronic myelogenous leukemia (CML), and the drug, Gleevec, a targeted therapy for AML will be discovered.
Produktinformation
- Utgivningsdatum: 2009-11-18
- Mått: 160 x 241 x 23 mm
- Vikt: 607 g
- Format: Inbunden
- Språk: Engelska
- Serie: Cancer Treatment and Research
- Antal sidor: 280
- Upplaga: 2010
- Förlag: Springer-Verlag New York Inc.
- ISBN: 9780387692579
Utforska kategorier
Mer information
Lalitha Nagarajan is an Associate Professor, Department of Molecular Genetics, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
Butikslager
Ej i lager i butik.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.